ZeGang Ma, Yu Zhou, JunXia Xie
Index: Neurotox. Res. 22(4) , 274-9, (2012)
Full Text: HTML
The mechanisms of iron accumulation in substantia nigra (SN) of Parkinson's diseases remain unclear. The objective of this study was to investigate effects of nifedipine on iron-overload-induced iron accumulation and neurodegeneration in SN of rats. By high performance liquid chromatography-electrochemical detection, tyrosine hydroxylase (TH) immunohistochemistry, and iron content array, we first quantified iron content and the number of dopamine neurons in SN of experimental rats treated with iron dextran. We further assessed effects of treatment with nifedipine. Our results showed that nifedipine treatment prevents iron dextran-induced dopamine depletion in the striatum. Consistently, we found that nifedipine restores the number of TH-positive neurons reduced by iron dextran overload and prevents increase of iron content in the SN. These results suggested that nifedipine may suppress iron toxicity in dopamine neurons and prevent neurodegeneration.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Iron dextran
CAS:9004-66-4 |
H2O4S.Fe |
Deferasirox shows in vitro and in vivo antileukemic effects ...
2013-06-01 [Exp. Hematol. 41(6) , 539-46, (2013)] |
[Importance of the different i.v. iron generations for every...
2013-03-21 [MMW Fortschr. Med. 155 Suppl 1 , 18-24, (2013)] |
Use of intravenous iron supplementation in chronic kidney di...
2013-01-01 [Iran. J. Kidney Dis. 7(1) , 9-22, (2013)] |
[Safety aspects of parenteral iron supplementation therapies...
2013-06-01 [Dtsch. Med. Wochenschr. 138(24) , 1312-7, (2013)] |
Iron dextran treatment does not induce serum protein carbony...
2012-01-01 [Animal 6(1) , 79-86, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved